Author:
van Stigt Arthur H.,Oude Rengerink Katrien,Bloemenkamp Kitty W. M.,de Waal Wouter,Prevaes Sabine M. P. J.,Le Thuy-My,van Wijk Femke,Nederend Maaike,Hellinga Anneke H.,Lammers Christianne S.,den Hartog Gerco,van Herwijnen Martijn J. C.,Garssen Johan,Knippels Léon M. J.,Verhagen Lilly M.,de Theije Caroline G. M.,Lopez-Rincon Alejandro,Leusen Jeanette H. W.,van’t Land Belinda,Bont Louis,Knulst André C.,van der Ent C. Kors,van Baarle Debbie,Wauben Marca H. M.,Rots Nynke Y.,Sanders Elisabeth A. M.,Benders Manon J. N. L.,Meulenbroek Laura A. M. P.,Stahl Bernd,Kraneveld Aletta D.,Buiteman Brigitte J. M.,Voogt Tanja,van der Meij Barbara,Lerkvaleekul Butsabong,Voogd Eline,Lammers Christianne S.,Lalmahomed Tariq A.,Brus Iris M.,van Meerwijk Daphne M. M.,Jepma Sophie I. E.,
Abstract
Abstract
Background
Many studies support the protective effect of breastfeeding on respiratory tract infections. Although infant formulas have been developed to provide adequate nutritional solutions, many components in human milk contributing to the protection of newborns and aiding immune development still need to be identified. In this paper we present the methodology of the “Protecting against Respiratory tract lnfections through human Milk Analysis” (PRIMA) cohort, which is an observational, prospective and multi-centre birth cohort aiming to identify novel functions of components in human milk that are protective against respiratory tract infections and allergic diseases early in life.
Methods
For the PRIMA human milk cohort we aim to recruit 1000 mother–child pairs in the first month postpartum. At one week, one, three, and six months after birth, fresh human milk samples will be collected and processed. In order to identify protective components, the level of pathogen specific antibodies, T cell composition, Human milk oligosaccharides, as well as extracellular vesicles (EVs) will be analysed, in the milk samples in relation to clinical data which are collected using two-weekly parental questionnaires. The primary outcome of this study is the number of parent-reported medically attended respiratory infections. Secondary outcomes that will be measured are physician diagnosed (respiratory) infections and allergies during the first year of life.
Discussion
The PRIMA human milk cohort will be a large prospective healthy birth cohort in which we will use an integrated, multidisciplinary approach to identify the longitudinal effect human milk components that play a role in preventing (respiratory) infections and allergies during the first year of life. Ultimately, we believe that this study will provide novel insights into immunomodulatory components in human milk. This may allow for optimizing formula feeding for all non-breastfed infants.
Funder
Nutricia Research Foundation
Universitair Medisch Centrum Utrecht
Ministerie van Volksgezondheid, Welzijn en Sport
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献